New therapeutic opportunities for women with low-grade serous ovarian cancer

Moujaber, T; Balleine, RL; Gao, B; Madsen, I; Harnett, PR; DeFazio, A

DeFazio, A (通讯作者),Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW, Australia.;DeFazio, A (通讯作者),Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.;DeFazio, A (通讯作者),Western Sydney Local Hlth Dist, Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW, Australia.;DeFazio, A (通讯作者),Univ Sydney, Daffodil Ctr, Joint Venture Canc Council New South Wales, Sydney, NSW, Australia.

ENDOCRINE-RELATED CANCER, 2022; 29 (1): R1

Abstract

Low-grade serous ovarian cancer (LGSC) is a morphologically and molecularly distinct subtype of ovarian cancer, accounting for similar to 10% of serou......

Full Text Link